Eldelumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eldelumab" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

1creativebiolabs.net

low place

low place

3,257^th place

3,398^th place

274^th place

309^th place

ama-assn.org

Statement On A Nonproprietary Name Adopted By The USAN Council - Eldelumab, American Medical Association.

creativebiolabs.net

"Anti-CXCL10 Therapeutic Antibody (eldelumab) - Creative Biolabs". www.creativebiolabs.net. Retrieved 2017-03-24.

doi.org

Sandborn WJ, Colombel JF, Ghosh S, Sands BE, Dryden G, Hébuterne X, et al. (April 2016). "Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study". Journal of Crohn's & Colitis. 10 (4): 418–28. doi:10.1093/ecco-jcc/jjv224. PMC 4946756. PMID 26721935.

nih.gov

ncbi.nlm.nih.gov

Sandborn WJ, Colombel JF, Ghosh S, Sands BE, Dryden G, Hébuterne X, et al. (April 2016). "Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study". Journal of Crohn's & Colitis. 10 (4): 418–28. doi:10.1093/ecco-jcc/jjv224. PMC 4946756. PMID 26721935.

pubmed.ncbi.nlm.nih.gov

Sandborn WJ, Colombel JF, Ghosh S, Sands BE, Dryden G, Hébuterne X, et al. (April 2016). "Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study". Journal of Crohn's & Colitis. 10 (4): 418–28. doi:10.1093/ecco-jcc/jjv224. PMC 4946756. PMID 26721935.

springer.com

adisinsight.springer.com

"Eldelumab". AdisInsight. Springer Nature Switzerland AG.